American Society of Hirudotherapy

Smart Library

Faceted search across all 5 registries. Filter by registry type, evidence level, or safety domain.

Curated knowledge library: Content describes science, methodology, or organizational reference material — not a clinical efficacy claim.Reference collection: Content is historical, educational, or biographical reference material — not a clinical recommendation.

New to hirudotherapy? Start here

This library indexes the full evidence base. For orientation, begin with the core guides:

Conditions

174

Venous Congestion in Surgical Flaps

Tier A

FDA-cleared application: medicinal leech therapy to relieve venous congestion in compromised tissue flaps awaiting vascular ingrowth.

FDA-cleared device indication: FDA has cleared Hirudo medicinalis as a medical device (K040187, June 21 2004) for venous congestion in surgical flaps. Other uses are off-label or investigational.FDA-cleared regulatory context

Microsurgical Replantation (Digit / Ear / Scalp)

Tier A

FDA-cleared application: post-replantation venous decompression in digits, ears, scalp, and partial avulsion injuries.

FDA-cleared device indication: FDA has cleared Hirudo medicinalis as a medical device (K040187, June 21 2004) for venous congestion in surgical flaps. Other uses are off-label or investigational.FDA-cleared regulatory context

Breast Reconstruction Flap Salvage

Tier A

FDA-cleared application: venous decompression of compromised DIEP, TRAM, and latissimus dorsi flaps in post-mastectomy reconstruction.

FDA-cleared device indication: FDA has cleared Hirudo medicinalis as a medical device (K040187, June 21 2004) for venous congestion in surgical flaps. Other uses are off-label or investigational.FDA-cleared regulatory context

Knee Osteoarthritis

Tier B

Off-label use; several small RCTs in knee OA report pain and function improvement with leeches versus NSAID gel, sham leech or TENS, though results against sham and TENS are mixed, and a 2022 trial against physiotherapy found no therapeutic effect.

Studied off-label: Off-label use means application outside the FDA-cleared indication. Clinical evidence (RCTs or systematic reviews) supports this use, but the FDA has not cleared it.Systematic review

Rheumatoid Arthritis

Tier C

No published clinical study of leech therapy in rheumatoid arthritis was identified; early disease-modifying treatment remains the standard, and leeches must never replace or delay it.

Investigational: Limited human evidence exists (small trials, case series, or pilot studies). Use is investigational and should be considered carefully under clinician guidance.Insufficient evidence

Thumb Carpometacarpal (CMC-1) Osteoarthritis

Tier B

Off-label use with one small RCT (Michalsen 2008, 32 women) in which single-session leech therapy reduced pain and improved hand function more than topical diclofenac for about 2 months.

Studied off-label: Off-label use means application outside the FDA-cleared indication. Clinical evidence (RCTs or systematic reviews) supports this use, but the FDA has not cleared it.RCT

Lateral Epicondylitis (Tennis Elbow)

Tier B

Off-label use with one small RCT (Bäcker 2011, n=40) in which a single leech session reduced pain more than topical diclofenac at day 7; the pain difference was no longer significant at day 45.

Studied off-label: Off-label use means application outside the FDA-cleared indication. Clinical evidence (RCTs or systematic reviews) supports this use, but the FDA has not cleared it.RCT

Plantar Fasciitis

Tier C

Investigational use; no clinical study of leech therapy for plantar fasciitis was identified, and the rationale is mechanistic only.

Investigational: Limited human evidence exists (small trials, case series, or pilot studies). Use is investigational and should be considered carefully under clinician guidance.Insufficient evidence

Chronic Venous Insufficiency (CEAP C3-C5)

Tier B

Off-label adjunct to compression; the journal evidence is one small open-label randomized trial in varicose veins (n=50) and a 20-patient uncontrolled series; the books describe further reports (see “What the books describe” below).

Studied off-label: Off-label use means application outside the FDA-cleared indication. Clinical evidence (RCTs or systematic reviews) supports this use, but the FDA has not cleared it.RCT

Venous Leg Ulcer

Tier B

Off-label adjunct to compression therapy; the journal evidence is one 20-patient uncontrolled series in complicated varicose veins plus case reports; the books add an older report on trophic ulcers of unspecified origin (see “What the books describe” below).

Studied off-label: Off-label use means application outside the FDA-cleared indication. Clinical evidence (RCTs or systematic reviews) supports this use, but the FDA has not cleared it.Cohort / case series

Post-Thrombotic Syndrome

Tier C

Investigational use; no controlled trial was identified, and the only clinical report is a 1998 conference series of 87 patients without a comparison group.

Investigational: Limited human evidence exists (small trials, case series, or pilot studies). Use is investigational and should be considered carefully under clinician guidance.Insufficient evidence

Chronic Rhinosinusitis

Tier B

Investigational use for chronic rhinosinusitis; no clinical study of leech therapy for this condition was identified, and the rationale is mechanistic.

Studied off-label: Off-label use means application outside the FDA-cleared indication. Clinical evidence (RCTs or systematic reviews) supports this use, but the FDA has not cleared it.RCT

Cervical Radiculopathy

Tier C

Investigational use for cervical radiculopathy; no verifiable published trial specific to this indication.

Investigational: Limited human evidence exists (small trials, case series, or pilot studies). Use is investigational and should be considered carefully under clinician guidance.Mechanistic

Lumbar Radiculopathy (Sciatica)

Tier C

Investigational use for lumbar radiculopathy; the closest randomized evidence is in chronic low back pain (Hohmann 2018, n=44), not radicular pain.

Investigational: Limited human evidence exists (small trials, case series, or pilot studies). Use is investigational and should be considered carefully under clinician guidance.RCT

Chronic Low Back Pain (nonspecific)

Tier B

One small, unblinded randomized trial (Hohmann 2018, n=44): back pain was lower 4 weeks after leech therapy than after exercise therapy; follow-up 8 weeks.

Studied off-label: Off-label use means application outside the FDA-cleared indication. Clinical evidence (RCTs or systematic reviews) supports this use, but the FDA has not cleared it.RCT

Migraine

Tier C

Investigational use; the only clinical studies found in journal searches are a 7-patient case series and a 26-patient non-randomized pilot (older reports are described in “What the books describe”), and the proposed mechanism is hypothetical.

Investigational: Limited human evidence exists (small trials, case series, or pilot studies). Use is investigational and should be considered carefully under clinician guidance.Mechanistic

Tension-Type Headache

Tier C

Investigational use for chronic tension-type headache; no study for this headache type was identified, and the proposed mechanism (muscle tension, venous congestion) is untested.

Investigational: Limited human evidence exists (small trials, case series, or pilot studies). Use is investigational and should be considered carefully under clinician guidance.Insufficient evidence

Essential Hypertension (Adjunctive)

Tier C

Investigational adjunctive use with only non-randomized clinical reports identified; proposed mechanisms are blood-volume removal and hirudin effects on vessels; not a substitute for pharmacotherapy.

Investigational: Limited human evidence exists (small trials, case series, or pilot studies). Use is investigational and should be considered carefully under clinician guidance.Cohort / case series

Varicose Veins (Symptomatic Tributaries)

Tier C

Investigational use for symptomatic relief of varicose tributary discomfort and inflammation; does not eliminate underlying venous reflux.

Investigational: Limited human evidence exists (small trials, case series, or pilot studies). Use is investigational and should be considered carefully under clinician guidance.RCT

Hemorrhoids (Grade II-III, Symptomatic)

Tier C

Investigational use for symptomatic relief of grade II-III internal/external hemorrhoidal disease; does not address anatomic prolapse.

Investigational: Limited human evidence exists (small trials, case series, or pilot studies). Use is investigational and should be considered carefully under clinician guidance.Cohort / case series

Glaucoma (Adjunctive)

Tier C

Investigational adjunctive use in primary open-angle glaucoma; weak case-series evidence. Not a substitute for IOP-lowering eye drops or surgery.

Investigational: Limited human evidence exists (small trials, case series, or pilot studies). Use is investigational and should be considered carefully under clinician guidance.Cohort / case series

Dry Eye Syndrome

Tier C

Investigational use for dry eye disease; no clinical study of leech therapy was identified, and the proposed meibomian-gland mechanism is hypothetical.

Investigational: Limited human evidence exists (small trials, case series, or pilot studies). Use is investigational and should be considered carefully under clinician guidance.Insufficient evidence

Lactational Mastitis (Non-Suppurative)

Tier C

Investigational adjunctive use proposed for non-suppurative lactational mastitis; no clinical study of leech therapy was identified.

Investigational: Limited human evidence exists (small trials, case series, or pilot studies). Use is investigational and should be considered carefully under clinician guidance.Insufficient evidence

Fibromyalgia

Tier C

Investigational use only: no controlled clinical study of leech therapy for fibromyalgia was identified, and it is not a primary treatment.

Investigational: Limited human evidence exists (small trials, case series, or pilot studies). Use is investigational and should be considered carefully under clinician guidance.Insufficient evidence

Sciatica (Non-Discogenic / Piriformis)

Tier C

Investigational use for non-discogenic sciatica including piriformis syndrome; no controlled trial, only an old unquantified Russian case series.

Investigational: Limited human evidence exists (small trials, case series, or pilot studies). Use is investigational and should be considered carefully under clinician guidance.Cohort / case series

Raynaud's Syndrome (Primary)

Tier C

Investigational use for primary Raynaud's phenomenon; the only clinical report is three patients in a 2025 Azerbaijani case series, with no controlled trial.

Investigational: Limited human evidence exists (small trials, case series, or pilot studies). Use is investigational and should be considered carefully under clinician guidance.Case report

Livedo Reticularis

Tier C

Investigational use for primary livedo reticularis; no clinical study was identified. Secondary causes (lupus, APLAS) require rheumatology referral.

Investigational: Limited human evidence exists (small trials, case series, or pilot studies). Use is investigational and should be considered carefully under clinician guidance.Insufficient evidence

Lipodermatosclerosis

Tier C

Investigational use for chronic lipodermatosclerosis; no study in this condition was identified, only small series in venous ulcer and varicose disease.

Investigational: Limited human evidence exists (small trials, case series, or pilot studies). Use is investigational and should be considered carefully under clinician guidance.Insufficient evidence

Insulin Injection Lipohypertrophy

Tier C

Investigational use for insulin injection-related lipohypertrophy nodules; no clinical study of leech therapy for them was identified.

Investigational: Limited human evidence exists (small trials, case series, or pilot studies). Use is investigational and should be considered carefully under clinician guidance.Insufficient evidence

Androgenic Alopecia

Tier C

Investigational use for androgenic alopecia; the only clinical report is a single-patient Ayurvedic case study, with no controlled trial.

Investigational: Limited human evidence exists (small trials, case series, or pilot studies). Use is investigational and should be considered carefully under clinician guidance.Case report

Rosacea (Erythematotelangiectatic)

Tier C

Investigational use for erythematotelangiectatic rosacea; no clinical study of leech therapy was identified.

Investigational: Limited human evidence exists (small trials, case series, or pilot studies). Use is investigational and should be considered carefully under clinician guidance.Insufficient evidence

Plaque Psoriasis (Localized)

Tier C

Investigational adjunct, not a primary treatment; a few small, mostly uncontrolled studies report lower PASI scores.

Investigational: Limited human evidence exists (small trials, case series, or pilot studies). Use is investigational and should be considered carefully under clinician guidance.Cohort / case series

Atopic Eczema (Localized Refractory)

Tier C

Investigational use for localized refractory eczema; evidence is limited to a few small studies without placebo or standard-care controls.

Investigational: Limited human evidence exists (small trials, case series, or pilot studies). Use is investigational and should be considered carefully under clinician guidance.Cohort / case series

Keloid and Hypertrophic Scarring

Tier C

Investigational use for keloid and hypertrophic scars; evidence is limited to one small uncontrolled series and two conflicting single-patient reports.

Investigational: Limited human evidence exists (small trials, case series, or pilot studies). Use is investigational and should be considered carefully under clinician guidance.Cohort / case series

Chronic Recurrent Cellulitis

Tier C

Investigational use for chronic recurrent (non-acute) cellulitis with underlying lymphedema or venous insufficiency.

Investigational: Limited human evidence exists (small trials, case series, or pilot studies). Use is investigational and should be considered carefully under clinician guidance.Insufficient evidence

Primary or Secondary Lymphedema

Tier C

Investigational adjunctive use; no clinical study of leech therapy for lymphedema was identified.

Investigational: Limited human evidence exists (small trials, case series, or pilot studies). Use is investigational and should be considered carefully under clinician guidance.Insufficient evidence

Acute Gout Flare

Tier C

Investigational use for acute monoarticular gout when NSAIDs and colchicine are contraindicated; evidence limited to a few small Ayurvedic pilot studies.

Investigational: Limited human evidence exists (small trials, case series, or pilot studies). Use is investigational and should be considered carefully under clinician guidance.Case report

Mid-Substance Achilles Tendinopathy

Tier C

Investigational use for chronic mid-substance Achilles tendinopathy; evidence limited to isolated single-patient reports.

Investigational: Limited human evidence exists (small trials, case series, or pilot studies). Use is investigational and should be considered carefully under clinician guidance.Case report

Rotator Cuff Tendinopathy

Tier C

Investigational use for non-surgical rotator cuff tendinopathy and chronic shoulder impingement; evidence limited to isolated case reports.

Investigational: Limited human evidence exists (small trials, case series, or pilot studies). Use is investigational and should be considered carefully under clinician guidance.Case report

Trigger Finger (Stenosing Tenosynovitis)

Tier C

Investigational use for stenosing tenosynovitis of the digital flexor pulleys; evidence limited to a single Ayurvedic case report.

Investigational: Limited human evidence exists (small trials, case series, or pilot studies). Use is investigational and should be considered carefully under clinician guidance.Case report

Dupuytren's Contracture (Early Stage)

Tier C

Investigational use in Dupuytren's disease; evidence limited to one uncontrolled Russian-language report in patients with contracture.

Investigational: Limited human evidence exists (small trials, case series, or pilot studies). Use is investigational and should be considered carefully under clinician guidance.Case report

Plantar Fibromatosis (Ledderhose Disease)

Tier C

Investigational use for plantar fascia nodules in early Ledderhose disease; no clinical study of leech therapy for this condition was identified.

Investigational: Limited human evidence exists (small trials, case series, or pilot studies). Use is investigational and should be considered carefully under clinician guidance.Case report

Peyronie's Disease (Stable Phase)

Tier C

Investigational use for stable-phase Peyronie's disease; evidence limited to one uncontrolled Russian series of 29 patients. Standard treatments (verapamil, collagenase, surgery) remain first-line.

Investigational: Limited human evidence exists (small trials, case series, or pilot studies). Use is investigational and should be considered carefully under clinician guidance.Mechanistic

Chronic Prostatitis / Chronic Pelvic Pain Syndrome (CP/CPPS)

Tier C

Investigational for category III CP/CPPS: evidence is limited to a 3-patient case report, an uncontrolled Russian series and a comparison in urogenital infection; multimodal therapy remains standard.

Investigational: Limited human evidence exists (small trials, case series, or pilot studies). Use is investigational and should be considered carefully under clinician guidance.Cohort / case series

Endometriosis-Related Pelvic Pain

Tier C

Investigational adjunctive use for chronic endometriosis-related pelvic pain; very limited evidence. Not a substitute for hormonal or surgical management.

Investigational: Limited human evidence exists (small trials, case series, or pilot studies). Use is investigational and should be considered carefully under clinician guidance.Cohort / case series

Primary Dysmenorrhea

Tier C

Investigational for primary dysmenorrhea; one small randomized trial of leeches plus cupping versus an oral contraceptive pill reported lower pain scores.

Investigational: Limited human evidence exists (small trials, case series, or pilot studies). Use is investigational and should be considered carefully under clinician guidance.RCT

Chronic Pelvic Pain Syndrome (Non-Specific)

Tier C

Investigational for non-specific chronic pelvic pain; the only clinical report located is an uncontrolled 60-woman series in which leeches were one part of multimodal care.

Investigational: Limited human evidence exists (small trials, case series, or pilot studies). Use is investigational and should be considered carefully under clinician guidance.Cohort / case series

Subjective Tinnitus

Tier C

Investigational for tinnitus; small non-randomized studies, mostly Russian, report less ear noise, and no study using the Tinnitus Handicap Inventory was identified.

Investigational: Limited human evidence exists (small trials, case series, or pilot studies). Use is investigational and should be considered carefully under clinician guidance.Cohort / case series

Ménière's Disease (Adjunctive)

Tier C

Investigational adjunct for Ménière's disease with no clinical study identified; standard management (diet, betahistine, intratympanic therapy) remains primary.

Investigational: Limited human evidence exists (small trials, case series, or pilot studies). Use is investigational and should be considered carefully under clinician guidance.Insufficient evidence

Deep Vein Thrombosis (Post-Acute Phase Symptoms)

Tier C

Investigational use for residual symptoms in the post-acute phase of DVT (>6 weeks); contraindicated in acute DVT.

Investigational: Limited human evidence exists (small trials, case series, or pilot studies). Use is investigational and should be considered carefully under clinician guidance.Insufficient evidence

Showing first 50 of 174. Refine filters to narrow results.

This website provides educational information and does not constitute medical advice, diagnosis, or treatment recommendations. Medicinal leech therapy carries clinically meaningful risks and should be performed only by qualified clinicians under institutionally approved protocols. FDA 510(k) clearance for medicinal leeches is limited to specific indications; investigational and off-label discussions are labeled accordingly. For patient-specific guidance, consult a qualified healthcare provider.

Smart Library — Faceted Search Across All Registries | ASH